Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0875-2026Class II

Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography

GE Healthcare / initiated 2025-10-24 / Open, Classified / root cause: labeling and UDI

GE Medical Systems, LLC began a recall of Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography on . FDA classified it as Class II and gives the reason as "Some Senographe Pristina systems either have a missing or an incorrect X-Ray Warning label, which is a nonconformance to FDA Regulation 21 CFR 1020.30(j)". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0875-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
GE Healthcare
Product
Senographe Pristina, Pristina Serena, and Pristina Serena 3D. for screening and diagnostic mammography
Product code
MUE Full Field Digital, System, X-Ray, Mammographic
Reason for recall
Some Senographe Pristina systems either have a missing or an incorrect X-Ray Warning label, which is a nonconformance to FDA Regulation 21 CFR 1020.30(j).
Root cause tag
labeling and UDI
FDA root cause
Radiation Control for Health and Safety Act
Action
GE Healthcare notified sent customers notification letter dated October 24, 2025 and instructed in the letter, the customer will inspect and identify systems that have a missing or incorrect label.
Quantity in commerce
1,818 (1,580 US; 238 OUS)
Distribution
U.S. and OUS.
Product codes and lots
GTINs: 00840682118460, 00840682142052, 00840682145879, 00195278022745, 00195278276971, 00195278661999, 00195278665379, 00195278914026

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0875-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0875-2026Class IIOngoingFDA Mandated